Biomerieux SA

Biomerieux SA is a global biotechnology company headquartered in France, specializing in in vitro diagnostics and microbiological testing systems. Registered in SAM.gov since 2006, the company is classified as a foreign-owned, for-profit organization and manufacturer of goods that provides advanced medical diagnostic solutions to federal agencies. The company's federal contract profile demonstrates expertise in providing specialized medical diagnostic equipment and related maintenance services to both defense and civilian government healthcare installations.

The federal contract awards for Biomerieux SA reveal a focused portfolio of medical diagnostic technology procurement, specifically centered on VITEK 2 diagnostic systems and associated test cards. The most recent contract with the Defense Health Agency (DHA) involves a sole-source procurement for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan, which includes the purchase of multiple types of VITEK 2 antimicrobial susceptibility test cards and preventative maintenance for VITEK 2 Compact Analyzer instruments. The contract, valued at $81,218.56, spans a base year and two option years through September 30, 2027. A separate contract with the Plains Area civilian agency involved the procurement of a VITEK 2 Compact 30 System with 50 boxes of AST and ID cards, indicating the company's consistent focus on providing advanced diagnostic testing equipment to federal healthcare entities.

While the available data shows limited information about indefinite delivery/indefinite quantity (IDV) contracts, the existing contract awards suggest Biomerieux SA operates primarily through direct purchase orders with specific federal healthcare agencies. The contracts are consistently non-set-aside and appear to be firm fixed-price arrangements, targeting specific diagnostic technology needs. The company's federal contracting strategy seems concentrated on providing specialized microbiological testing systems, particularly the VITEK 2 diagnostic platform, to military and civilian healthcare institutions. The contracts demonstrate a clear specialization in providing high-precision medical diagnostic equipment and associated maintenance services, with a particular emphasis on antimicrobial susceptibility testing technologies for federal medical facilities.